期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

PI_3K/Akt/mTOR通路与急性早幼粒细胞白血病关系的研究进展 被引量：5

Advances on PI_3K/Akt/mTOR Signaling Network in Acute Promyelocytic Leukemia
暂未订购
导出
摘要 PI3K/Akt/mTOR信号途径作为细胞内重要信号转导通路之一,在维持细胞增殖、存活和凋亡中发挥关键作用。当PI3K/Akt/mTOR通路分子的基因功能失常、上游调控信号异常放大时使该信号通路异常激活,细胞生存与凋亡失衡,正常细胞发生恶性转化。研究表明,PI3K/Akt/mTOR信号通路在急性早幼粒细胞白血病存在异常激活,对肿瘤细胞的生存、增殖、分化、凋亡和耐药性中起重要作用。现就近年来在PI3K/Akt/mTOR信号通路与急性早幼粒细胞白血病关系研究领域的进展予以简要综述。 Phosphatidylinositol 3-kinase（PI3K）/Akt/mammalian target of rapamycin（mTOR） signaling axis is an important intracellular signal transduction pathway and plays a central role in cell proliferation,growth,and survival under physiological conditions.Aberrant activation of PI3K/Akt/mTOR signaling due to genetic dysfunction and abnormal magnification of upstream regulatory signal results in the imbalance between cell viability and apoptosis and malignant transformation.It has been shown that the constitutive activation of PI3K/Akt/mTOR signaling network in acute promyelocytic leukemia plays a vital role in survival,proliferation,differentiation,apoptosis,and drug-resistance of leukemic cells.This article reviews recent progress on PI3K/Akt/mTOR signaling axis in acute promyelocytic leukemia.
作者 刘梅 谢捷明 刘庭波
机构地区 福建医科大学附属协和医院血液病研究所 福建医科大学药学院
出处 《医学综述》 2011年第7期966-969,共4页 Medical Recapitulate
基金 国家自然科学基金(30772587) 福建省自然科学基金(C0510012) 福建医科大学科学研究发展基金(FJGXY04019)
关键词 PI3K/Akt/mTOR信号通路 急性早幼粒细胞白血病 分化 耐药 凋亡 PI3K/Akt/mTOR signaling network Acute promyelocytic leukemia Differentiation Resistance Apoptosis
分类号 R551.3 [医药卫生—血液循环系统疾病] R34 [医药卫生—基础医学]
  • 相关文献

参考文献30

  • 1Wang ZY,Chen Z.Acute promyelocytie leukemia:from highly fatal to highly curable[J].Blood,2008,111(5):2505-2515.
  • 2Xu Q,Simpson SE,Scialla TJ,et al.Survival of acute myeloid leukemia cells requires PI3 kinase activation[J].Blood,2003,102(3):972-980.
  • 3Kubota Y,Ohnishi H,Kitanaka A,et al.Constitutive activation of PI3K is involved in the spontaneous proliferation of primary acute myeloid leukemia cells:direct evidence of PI3K activation[J].Leukemia,2004,18(8):1438-1440.
  • 4Min YH,Eom JI,Cheong JW,et al.Constitutive phosphorylation of Akt/PKB protein in acute myeloid leukemia:its significance as a prognostic variable[J].Leukemia,2003,17(5):995-997.
  • 5Ishida S,Shigemoto-Mogami Y,Shinozaki Y,et al.Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid and Am80-induced HL-60 cell differentiation revealed by DNA microarray analysis[J].Biochem Pharmacol,2004,68(11):2177-2186.
  • 6Nishioka C,Ikezoe T,Yang J,et al.Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells[J].Leukemia,2008,22(12):2159-2168.
  • 7Billottet C,Banerjee L,Vanhaesebroeck B,et al.Inhibition of class Ⅰ phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-Induced differentiation[J].Cancer Res,2009,69(3):1027-1036.
  • 8Cantley LC.The phosphoinositide 3-kinase pathway[J].Science,2002,296(5573):1655-1657.
  • 9Huang J,Manning BD.A complex interplay between Akt,TSC2 and the two mTOR complexes[J].Biochem Soc Trans,2009,37(Pt 1):217-222.
  • 10Guan L,Han B,Li Z,et al.Sodium selenite induces apoptosis by ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction in human acute promyelocytic leukemia NB4 cells[J].Apoptosis,2009,14(2):218-225.

二级参考文献3

  • 1贝政平，3200个内科疾病诊断标准，1998年
  • 2张之南，血液病诊断及疗效标准（第2版），1998年
  • 3王世俊，金属中毒（第2版），1988年

共引文献319

同被引文献57

  • 1李丽（综述）,张日（审校）.mTOR信号通路与白血病靶向治疗研究进展[J].国际输血及血液学杂志,2007,30(2):168-172. 被引量：2
  • 2张鹏霞,刘淼,陈东,魏晓东,葛堂栋.齐墩果酸对HL60细胞周期调控因子影响的实验研究[J].中国老年学杂志,2007,27(9):825-827. 被引量：6
  • 3Humlg WL,Zhu XE. Signal transduction[M]. Beijing: People's Medical Publishing House ,2005 : 151-99.
  • 4Cheng GZ,Park S,Shu S,et al. Adances of Akt pathway in human onco- gensis and as a target for anti-cancer drug discovery. [J] Curr Cancer Drug Targets,2008 ;8( 1 ) :2-6.
  • 5Vlahos CJ, Matter WF, Hui KY, et al. A specific inhihitor of phosphati- dylinositol-3-kinase, 2-( 4-mor-pholinyl )-$-phenyl4H-l-benzopyran-4- One ( LY294002 ) [J]. Biol Chem, 1994 ;269 ( 7 ) :5241-8.
  • 6Barancik M, Bohacova V, Sedlak J,et al. LY294002, a specific inhibitor of PI3K/Aktkinase pathway, antagonizes P-glycoprotein-mediated muhidrug resistance [ J ]. Eur J Pharm Sci,2006 ;29 ( 5 ) :426.
  • 7Ma J. PTEN regulate angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells[J] Mole Cell Biochem ,2009; 11 (351) :161-71.
  • 8Chao X,Zao J, Gu XY,et aL Blocking of PI3K/Akt imtuces apoptosis by its effect on NF-KB activity in gastriccarcinoma cell line SGC7901[J]. Biomed Pharmacother,2010; I 1 (64) :6004.
  • 9Wong KK,Engelman JA, Cantley LC. Targeting the PI3K signaling path- way in cancer[J]. Curr Opin,2010;2(20) :87-90.
  • 10Martelli AM,Evangelisti C, Chiarini F,et al. The phosphatidylinosi-tol 3- kinase/Akt/mTOR signaling network as a therapeutic target in acute my- elogenous leukemia patients[J]. Oncotarget,2010;6( I ) :89-103.

引证文献5

二级引证文献23

医学综述
2011年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部